Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: A randomized non-inferiority trial

被引:75
|
作者
Choi, Jeong Yeon [1 ,2 ]
Lee, Hye Sun [3 ]
Kim, Ji Young [1 ,2 ]
Han, Dong Woo [1 ,2 ]
Yang, Ju Yeon [3 ]
Kim, Min Jae [1 ]
Song, Young [1 ,2 ,4 ]
机构
[1] Yonsei Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Anesthesia & Pain Res Inst, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, 211 Eonjuro, Seoul 06273, South Korea
关键词
Remimazolam; Propofol; Anesthesia; Quality of recovery; Female; Thyroid surgery; GENERAL-ANESTHESIA; REMIFENTANIL; SURGERY; MIDAZOLAM; SEDATION; SCORE; AGE;
D O I
10.1016/j.jclinane.2022.110955
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Study objective: The quality of recovery (QoR) of remimazolam-based and propofol-based total intravenous anesthesia was compared as measured by QoR-15 scores.Design: A prospective, double-blind, randomized controlled, non-inferiority trial.Setting: An operating room, a post-anesthesia care unit (PACU), and a hospital ward.Patients: Female patients (n = 140; 20-65 years) scheduled for open thyroidectomy were enrolled and randomly assigned to the remimazolam or propofol group.Interventions: The remimazolam group received continuous remimazolam infusions and effect-site target -controlled remifentanil infusions. The propofol group received effect-site target-controlled infusions of propofol and remifentanil. Measurements: The primary outcome was QoR-15 on postoperative day 1 (POD1). The mean difference between the groups was compared against a non-inferiority margin of-8. Secondary outcomes were QoR-15 on POD2, hemodynamic data, time to lose and recover consciousness, sedation score upon PACU admission, pain, and postoperative nausea and vomiting profiles at the PACU and ward. Group-time interaction effects in hemody-namic data and QoR-15 were analyzed using a linear mixed model.Main results: The total QoR-15 score on POD1 in the remimazolam group was non-inferior to that in the propofol group (mean [SD] 111.2 [18.8] vs. 109.1 [18.9]; mean difference [95% CI] 2.1 [-4.2, 8.5]; p = 0.002 for non -inferiority). The QoR-15 score on POD2 was comparable between the groups, and no group-time interaction was observed. At the end of anesthesia, after extubation, and upon arrival at the PACU, mean arterial pressure was significantly higher in the remimazolam group. Remimazolam group was more sedated at the time of admission to PACU. Pain intensity and the requirement for analgesics were lower in the remimazolam group than in the propofol group.Conclusions: Remimazolam-based total intravenous anesthesia provided a similar QoR to propofol. Remimazolam and propofol can be used interchangeably for general anesthesia in female patients undergoing thyroid surgery.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Efficacy of sevoflurane as an adjuvant to propofol-based total intravenous anesthesia for attenuating secretions in ocular surgery
    Lai, Hou-Chuan
    Chang, Yun-Hsiang
    Huang, Ren-Chih
    Hung, Nan-Kai
    Lu, Chueng-He
    Chen, Jou-Hsiu
    Wu, Zhi-Fu
    MEDICINE, 2017, 96 (17)
  • [42] Propofol-based Total Intravenous Anesthesia Is Associated with Better Survival Than Desflurane Anesthesia in Colon Cancer Surgery
    Wu, Zhi-Fu
    Lee, Meei-Shyuan
    Wong, Chih-Shung
    Lu, Chueng-He
    Huang, Yuan-Shiou
    Lin, Kuen-Tze
    Lou, Yu-Sheng
    Lin, Chin
    Chang, Yue-Cune
    Lai, Hou-Chuan
    ANESTHESIOLOGY, 2018, 129 (05) : 932 - 941
  • [43] Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in intrahepatic cholangiocarcinoma surgery
    Lai, Hou-Chuan
    Lee, Meei-Shyuan
    Lin, Kuen-Tze
    Chan, Shun-Ming
    Chen, Jen-Yin
    Lin, Yao-Tsung
    Wu, Zhi-Fu
    MEDICINE, 2019, 98 (51)
  • [44] Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery
    Huang, Yi-Hsuan
    Lee, Meei-Shyuan
    Lou, Yu-Sheng
    Lai, Hou-Chuan
    Yu, Jyh-Cherng
    Lu, Chueng-He
    Wong, Chih-Shung
    Wu, Zhi-Fu
    PLOS ONE, 2019, 14 (11):
  • [45] Incidence of intraoperative hypotension in older patients undergoing total intravenous anesthesia by remimazolam versus propofol: A randomized controlled trial
    Jeon, Yeong-Gwan
    Kim, Sujin
    Park, Ji-Hyoung
    Lee, Jonghoon
    Song, Sang A.
    Lim, Hyun Kyo
    Song, Seung Woo
    MEDICINE, 2023, 102 (49) : E36440
  • [46] Propofol-based total intravenous anesthesia improves survival compared to desflurane anesthesia in gastric cancer surgery A retrospective analysis
    Huang, Nian-Cih
    Lee, Meei-Shyuan
    Lai, Hou-Chuan
    Lin, Han-Ting
    Huang, Yi-Hsuan
    Lu, Chueng-He
    Hsu, Chen-Heng
    Wu, Zhi-Fu
    MEDICINE, 2020, 99 (25) : E20714
  • [47] Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial
    Li, Zhi
    Yuan, Daming
    Yu, Yu
    Xu, Jie
    Yang, Weili
    Chen, Li
    Luo, Nanbo
    TRIALS, 2024, 25 (01)
  • [48] Comparison of Remimazolam Tosilate and Propofol Sedation on the Early Postoperative Quality of Recovery in Patients Undergoing Day Surgery: A Prospective Randomized Controlled Trial
    Zhang, Lijuan
    Wang, Zhe
    Liu, Yingge
    Zhang, Xiaobao
    Wu, Yong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1743 - 1754
  • [49] Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial
    Zhi Li
    Daming Yuan
    Yu Yu
    Jie Xu
    Weili Yang
    Li Chen
    Nanbo Luo
    Trials, 25
  • [50] The influence of propofol-based total intravenous anesthesia on postoperative outcomes in end-stage renal disease patients: A retrospective observation study
    Cho, Ho Bum
    Kim, Mun Gyu
    Park, Sun Young
    Song, Sanghoon
    Jang, Youn Sil
    Park, Suyeon
    Lee, Hyun Keun
    Yoo, Jae Hwa
    Chung, Ji Won
    Kim, Sang Ho
    PLOS ONE, 2021, 16 (07):